NEWPORT NEWS, Va., Dec. 20 /PRNewswire/ -- Dilon Technologies, LLC of Newport News, Virginia and Naviscan PET Systems, Inc. of San Diego, California have settled their lawsuit over Dilon's medical imaging equipment. On May 24, 2007 Naviscan filed suit against Dilon in the U.S. District Court for the Southern District of California for possible patent infringement of six U.S. patents directed to technology for detecting breast cancer. The parties were able to quickly resolve the matter to the great satisfaction of Dilon's President, Lon Slane, and General COB, Bob Moussa. With the lawsuit now behind them, the parties are hopeful that joint cooperation will be part of their futures as they seek to advance the fight against breast cancer.
About Dilon Technologies
Dilon Technologies is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging procedure that images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; Northwestern Memorial Hospital, Chicago; and The Rose, Houston. For more information on Dilon Technologies please visit http://www.dilon.com.
CONTACT: Nancy F. Morter of Dilon Technologies, Inc., +1-757-269-4910,
ext. 302, cell, +1-757-589-3914, nfmorter@dilon.com
Web site: http://www.dilon.com/
